XASX
DOC
Market cap30mUSD
Oct 09, Last price
0.13AUD
1D
8.33%
1Q
6.56%
IPO
-84.97%
Name
Doctor Care Anywhere Group PLC
Chart & performance
P/E
21.47
P/S
0.65
EPS
0.00
Div yield, %
—
Shrs. gr., 5y
19.23%
Rev. gr., 5y
27.13%
Revenues
38m
-2.30%
Net income
1m
P
CFO
5m
+1,293.45%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Doctor Care Anywhere Group PLC, together with its subsidiaries, provides digital healthcare and development services in the United Kingdom and the Republic of Ireland. It offers services in the areas of medical letters, imaging support, blood testing, and mental health support, as well as comprehensive health assessments, health solutions, specialist care pathways, physiotherapy support, and GP and ACP appointments. The company provides treatments for allergies, intolerances, colds, flu, minor illnesses, gut health, joint, muscles, lifestyle support, men’s and women’s health, mental health, sexual health, and skin conditions. Doctor Care Anywhere Group PLC was founded in 2013 and is headquartered in Mayfair, the United Kingdom.
Key people
Niall Dore
Interim Chief Financial Officer · since 2025
Seema Sangar
Chief Financial Officer · since 2024
Cathy Baxandall
Interim Company Secretary · since 2024
Company Secretary · since 2025
Laura O'Riordan
Chief Executive Officer, Director · since 2025
Matthew Addison
Non-Executive Director · since 2024
David Ravech
Non-Executive Director · since 2018
John Stier
Independent Non-Executive Chairman of the Board · since 2023
Samit Shah
Independent Non-Executive Director · since 2025
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | |||||||
Revenues | |||||||
Cost of revenue | |||||||
Unusual Expense (Income) | |||||||
NOPBT | |||||||
NOPBT Margin | |||||||
Operating Taxes | |||||||
Tax Rate | |||||||
NOPAT | |||||||
Net income | |||||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | |||||||
BB yield | |||||||
| Debt | |||||||
Debt current | |||||||
Long-term debt | |||||||
Deferred revenue | |||||||
Other long-term liabilities | |||||||
Net debt | |||||||
| Cash flow | |||||||
Cash from operating activities | |||||||
CAPEX | |||||||
Cash from investing activities | |||||||
Cash from financing activities | |||||||
FCF | |||||||
| Balance | |||||||
Cash | |||||||
Long term investments | |||||||
Excess cash | |||||||
Stockholders' equity | |||||||
Invested Capital | |||||||
ROIC | |||||||
ROCE | |||||||
| EV | |||||||
Common stock shares outstanding | |||||||
Price | |||||||
Market cap | |||||||
EV | |||||||
EBITDA | |||||||
EV/EBITDA | |||||||
Interest | |||||||
Interest/NOPBT | |||||||